Trial Profile
A retrospective,analytical study investigating lymphocyte neutrophil relationship in patients with advanced kidney cancer treated with Pazopanib and Sunitinib
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jun 2017
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary) ; Sunitinib (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 02 Jun 2017 New trial record